Manipal Hospitals
| India | Turkey | Austria | |
| Radiation therapy for colorectal cancer | from $3,200 | from $7,000 | from $12,000 |
| Colectomy (large bowel resection) | from $5,500 | from $6,912 | from $22,000 |
| Chemotherapy for breast cancer | from $3,500 | from $1,200 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Sigmoid adenocarcinoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Sigmoid adenocarcinoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Sigmoid adenocarcinoma treatment journey.
Dr. Borde has handled over 30,000 PET scans and 1,000 thyroid cancer cases at HCG Manavata Cancer Centre.
Dr. Sarat Chandra P is an experienced oncologist at Manipal Hospitals, specializing in sigmoid adenocarcinoma.
Dr. Ajit Pai specializes in surgical treatment of gastrointestinal cancers, including sigmoid adenocarcinoma, at Apollo Hospital Indraprastha.
India aligns exactly with global National Comprehensive Cancer Network (NCCN) and European Society for Medical Oncology (ESMO) protocols. Standard treatments include laparoscopic surgical resection, multi-agent chemotherapy, and advanced targeted therapies. High-volume JCI-accredited centers utilize identical molecular profiling and drug dosing schedules used in Europe or the US.
Bookimed Expert Insight: While treatment protocols are identical, the sheer volume at centers like Manipal Hospitals or Apollo Hospital Indraprastha creates a unique expertise edge. Dr. Raj Nagarkar at HCG Manavata has performed over 50,000 surgeries, a number rarely matched by Western specialists. This massive clinical experience often leads to highly efficient surgical outcomes in complex sigmoid cases.
Patients with localized sigmoid adenocarcinoma in India can expect 5-year survival rates between 61% and 95%. Early Stage I cases show outcomes up to 94.7%. Specialized oncology centers often match international survival benchmarks through radical surgery and multidisciplinary tumor boards monitoring post-operative care.
Bookimed Expert Insight: Success in India is highly concentrated in centers that integrate advanced diagnostics like PET-CT with high-volume surgery Departments. Centers like HCG Manavata Cancer Centre and Global Hospital Chennai handle tens of thousands of oncology cases annually. Data suggests that clinics using computer-aided selections, such as IBM Watson at Manipal Goa, help oncologists align treatment precisely with global survival protocols.
Patient Consensus: Patients emphasize waiting for the final pathology report before judging long-term outlooks. They note that high-volume centers provide more accurate staging than smaller local clinics.
Minimally invasive surgery is widely available at major Indian tertiary centers. JCI-accredited facilities in Delhi, Chennai, and Mumbai routinely perform laparoscopic and robotic-assisted sigmoid colectomies. These approaches use 3 to 5 tiny abdominal incisions. This results in faster recovery times for patients.
Bookimed Expert Insight: Patient volume data suggests looking beyond general hospital reputation for colorectal procedures. Manipal Hospitals and Global Hospital Chennai serve approximately 2 million patients annually. These high-volume centers often maintain specialized teams with more experience in specific resections than smaller private clinics. This consistent practice is a key indicator of surgical proficiency in complex cancer cases.
Patient Consensus: Patients emphasize that surgical outcomes depend more on the specific oncology team than the hospital name. Many advise confirming how often a surgeon performs robotic colectomies for cancer before booking.
You will likely not need a permanent colostomy bag after a sigmoid colectomy. Most patients undergo successful anastomosis where surgeons reconnect the remaining healthy colon. This procedure restores normal bowel function. Permanent stomas are rare for sigmoid adenocarcinoma unless the cancer involves the rectum.
Bookimed Expert Insight: India ranks 9th globally for oncology requests on our platform due to massive surgical volumes. Dr. Raj Nagarkar at HCG Manavata has performed over 50,000 cancer surgeries. This high frequency allows surgeons to refine techniques that preserve the anal sphincter. Large networks like Apollo and Manipal handle millions of patients yearly. These centers have the specialized experience needed to avoid permanent stomas in complex sigmoid cases.
Patient Consensus: Patients note that surgeons often make the final decision during the operation based on tissue health. Many emphasize asking specifically if the plan includes a primary anastomosis or a temporary diversion.
Cancer surgeries for sigmoid adenocarcinoma are widely covered by Indian private insurance and government schemes. Policies classify sigmoid colectomy as a critical oncological procedure. Coverage typically includes hospitalization, surgeon fees, and anesthesia at accredited facilities like JCI-accredited Apollo Hospital Indraprastha or NABH-accredited Manipal Hospitals.
Bookimed Expert Insight: While many focus on the surgery, Indian oncology centers like HCG Manavata Cancer Centre and Manipal Hospitals often integrate advanced diagnostics like PET-CT into their workflows. Patients should note that while surgeries at centers with high volumes—some serving over 1,000,000 patients annually—are generally covered, specialized technologies like IBM Watson AI or robotic systems at Fortis Gurgaon may have specific sub-limits. Always verify if your insurer covers these modern surgical methods before proceeding.
Patient Consensus: Patients note that while major surgery is often covered, the `cancer pathway` including chemotherapy, colostomy supplies, and surveillance tests is frequently handled through separate insurance claims. They emphasize checking with the hospital insurance desk early since public cancer centers often have smoother approval processes for state schemes than smaller private clinics.
Leading Indian hospitals like Apollo Hospital Indraprastha and Manipal Hospitals provide high-volume sigmoid cancer management. These JCI and NABH-accredited centers utilize multidisciplinary tumor boards. Facilities combine advanced robotic surgery with PET-CT imaging and oncology expertise. Surgeons often handle over 1,000 colorectal procedures annually.
Bookimed Expert Insight: Data shows a clear advantage in seeking treatment at Nashik or Bengaluru for specialized oncology. While Delhi and Gurgaon clinics like Medanta offer massive 1,600-bed capacities, HCG Manavata in Nashik specifically reports treating 75,000 oncology patients annually. This high concentration of cancer-specific cases helps clinicians manage rare surgical complications more effectively than general multi-specialty hospitals.
Patient Consensus: Patients emphasize finding hospitals where pathology, surgery, and chemotherapy teams all work under one roof. They often note that private centers like Apollo or Fortis provide much faster access to treatment than public institutes.
Surgical resection is the primary treatment for sigmoid adenocarcinoma in India. Surgeons remove the affected bowel segment to eliminate the tumour. Advanced centres like HCG Manavata and Apollo Indraprastha routinely use laparoscopic or robotic-assisted techniques. These offer faster recovery and greater precision.
Bookimed Expert Insight: Indian oncology centres demonstrate exceptional surgical experience. Prof. Dr Raj Nagarkar at HCG Manavata alone has performed over 50,000 cancer surgeries. High surgery volumes and JCI and NABH accreditations at clinics like Apollo and Manipal ensure expertise that rivals top Western institutions. Costs are significantly lower.
Patient Consensus: Patients in India emphasise the importance of multi-disciplinary tumour boards in Delhi and Mumbai. These boards are essential for deciding whether to start with surgery or chemotherapy. They note that completing the full chemotherapy regimen is critical for long-term survival. This is especially important in advanced stages.
India offers treatment for sigmoid adenocarcinoma at JCI-accredited facilities like Apollo Hospital Indraprastha and HCG Manavata Cancer Centre. These hospitals specialise in robotic-assisted colectomies and laparoscopic resections. Leading oncology units use PET-CT imaging and multidisciplinary teams to manage complex colorectal cases.
Bookimed Expert Insight: While private hospitals like Apollo and Manipal offer VIP services, HCG Manavata Cancer Centre provides an audited research environment. Their US-FDA audited institute and team of 450+ oncologists process 30,000+ PET scans. This volume suggests a superior diagnostic baseline for staging sigmoid adenocarcinoma accurately.
Patient Consensus: Patients note that Tata Memorial Hospital in Mumbai remains the gold standard for complex gastrointestinal oncology. Those seeking shorter wait times often choose Apollo or Primus in Delhi for dedicated international patient teams.
Patients should plan an initial stay of 2 to 4 weeks in India. This covers sigmoid adenocarcinoma surgery and recovery. The timeframe also allows for diagnostic imaging, the procedure, and post-operative follow-up. Extended stays of 3 to 6 months are necessary. This applies if completing a full chemotherapy course locally.
Bookimed Expert Insight: Indian oncology centres often suggest a split-treatment model for international patients. Patients can complete the major surgery in India at high-volume centres. Manipal Hospitals is one such centre, serving 2,000,000 patients annually. After initial recovery, patients often return home to Australia. They receive chemotherapy under their local GP and specialist. With this approach, patients receive expert surgical care. They also spend less time away from their support network.
Patient Consensus: Patients note that staying roughly 2 weeks covers essential admission and immediate recovery in India. Many emphasise that bringing a family member helps significantly. It assists with daily care and learning recovery protocols before flying.
Medical tourism for sigmoid adenocarcinoma in India is a viable option. Leading Indian hospitals provide JCI-accredited care and technologies like robotic-assisted surgery and PET-CT. Specialists such as Prof. Dr Raj Nagarkar have performed over 50,000 cancer surgeries. This includes complex colorectal resections.
Bookimed Expert Insight: Clinical experience in India is exceptionally deep. At HCG Manavata Cancer Centre, specialists like Dr Chaitainya Borde have managed over 30,000 PET scans. This high volume helps doctors identify subtle spreads in sigmoid cases. Lower-volume centres might miss these. Most leading Indian oncologists also hold international credentials, such as MRCS from the UK.
Patient Consensus: Patients find that hospital social workers in India are helpful for navigating logistics. They suggest seeking treatment in Delhi NCR or Bengaluru. Many note that outcomes for stage 4 cases improve. This happens when chemotherapy successfully shrinks tumours before surgery. Success often depends on finding a specialist familiar with specific genetic mutations.
A consultation with an Indian oncologist should focus on tumour staging, biomarker testing, and surgical technique. Specialists at centres like Apollo Hospital Indraprastha use JCI-accredited protocols. They determine if chemotherapy or radiotherapy is needed before surgery. Ask about minimally invasive options and multidisciplinary team reviews.
Bookimed Expert Insight: Indian oncology centres often lead in high-volume surgical experience. Dr Raj Nagarkar at HCG Manavata Cancer Centre has performed over 50,000 cancer surgeries. This volume is significant for Australians. It means surgeons here often manage more sigmoid cases in one month. This is more than some regional specialists see in a year.
Patient Consensus: Patients in India recommend asking about biomarker testing immediately. They found that adding targeted drugs to standard chemotherapy significantly improved their results. It also improved their overall treatment experience.